Oxford Nanopore's announcement of its new whole-genome sequencing technology has set the genomics world talking once again about the $1,000 genome and how it could change research and healthcare. It "has the promise of taking the enterprise of sequencing an individual's genome out of the basic science laboratory, and out to the consumer mass market," says Razib Khan at The Crux blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.